Idraparinux sodiumProduct ingredient for Idraparinux
- Name
- Idraparinux sodium
- Drug Entry
- Idraparinux
Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X. It was developed for the treatment and prevention of thromboembolic events. However, clinical trials have revealed that idraparinux had lead to bleeding. As a result, Sanofi stopped the development of the drug.
- Accession Number
- DBSALT002010
- Structure
Structure for Idraparinux sodium (DBSALT002010)
- Synonyms
- Not Available
- External IDs
- ORG-34006 / SANORG34006